Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the safety, efficacy, and pharmacokinetics of Trans Sodium Crocetinate for intermittent claudication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication

Drugs mentioned

• Trans Sodium Crocetinate (trans-sodium crocetinate)

Snippet

Sponsor: Diffusion Pharmaceuticals Inc | Conditions: Intermittent Claudication | Phase 1, Phase 2 | Status: COMPLETED